Children affected by progeria, which is a rare disorder characterized by premature ageing, die in their teens of ailments like heart failure and stroke, which usually affects older individuals. Cao and her colleagues have taken a big step in that direction, showing that a toxic protein destroys muscle cells inside the patients' arteries. The researchers suspect the damaged arteries are thus primed for failure.
The researchers conducted their experiments on smooth muscle cells that they genetically engineered. "This gives us a very good model for testing drugs to treat progeria," said Cao, senior author of a research article published in the May 19, 2014 online Early Edition of the Proceedings of the National Academy of Sciences. "And it may help us understand how cardiovascular disease develops in people aging normally."
Progeria
'Paa' is a film in which Amitabh Bachchan, in a rare role reversal, plays son to Abhishek Bachchan, his real-life son!
Advertisement
Progeria is extremely rare—about 100 patients worldwide have been diagnosed—and always fatal at an early age. Patients typically die around age 13. The disorder is difficult to study because patients are so few, and their rapid decline mostly affects internal organs. That makes the effects hard to track without invasive testing, from which researchers want to spare the young patients.
Until now, researchers didn't know what mechanisms might be causing the patients' deaths. They knew a genetic mutation makes patients' cells produce progerin, a toxic form of a protein that, in healthy people, forms the skeletal structure of cell nuclei. In previous studies Cao and others found that progerin builds up in cells of elderly people, suggesting that it is also linked to normal aging. But progerin's effects on smooth muscle cells were unknown before this study.
![12- Year- Old South African Girl Battles Progeria , a Rare Premature Ageing Disease]( "12- Year- Old South African Girl Battles Progeria , a Rare Premature Ageing Disease")
Ontlametse Phalatse, from South Africa, is all of 12 years but looks like an old woman. She is suffering from a rare premature aging disease called Progeria.
Studies in mice with a genetically engineered form of progeria found the animals lost most of the smooth muscle cells in their large arteries. This muscle type, involved in involuntary movement, is in the lining of many internal organs, including blood vessels.
Cao's team couldn't obtain human smooth muscle cells from progeria patients for their study because the process would be too invasive, so they used induced pluripotent stem cells—adult cells reprogrammed to behave like embryonic stem cells and develop into a variety of cell types.
In a first for a progeria study, the researchers induced skin cells from progeria patients and normal adults to develop into smooth muscle cells, and then compared cell reproduction and decay in healthy cells with those same processes in cells containing the progeria mutation. Both sets of smooth muscle cells began multiplying, but after two weeks the progeria cells leveled off; as many cells were dying as were reproducing. The researchers discovered that the progeria cells accumulated toxic progerin and had abnormally low levels of PARP-1, a protein that is important in repairing cell damage.
Cells constantly repair damage to their DNA, Cao explained, and they have several ways to get the job done. When one strand in the DNA double helix breaks, cells usually use the unbroken strand as a template to make a perfect copy. PARP-1 is supposed to sense the break and start this repair process. In the study's normal smooth muscle cells, that's what happened.
Source: Eurekalert
12- Year- Old South African Girl Battles Progeria , a Rare Premature Ageing Disease
Ontlametse Phalatse, from South Africa, is all of 12 years but looks like an old woman. She is suffering from a rare premature aging disease called Progeria.
Advertisement
Studies in mice with a genetically engineered form of progeria found the animals lost most of the smooth muscle cells in their large arteries. This muscle type, involved in involuntary movement, is in the lining of many internal organs, including blood vessels.
Cao's team couldn't obtain human smooth muscle cells from progeria patients for their study because the process would be too invasive, so they used induced pluripotent stem cells—adult cells reprogrammed to behave like embryonic stem cells and develop into a variety of cell types.
In a first for a progeria study, the researchers induced skin cells from progeria patients and normal adults to develop into smooth muscle cells, and then compared cell reproduction and decay in healthy cells with those same processes in cells containing the progeria mutation. Both sets of smooth muscle cells began multiplying, but after two weeks the progeria cells leveled off; as many cells were dying as were reproducing. The researchers discovered that the progeria cells accumulated toxic progerin and had abnormally low levels of PARP-1, a protein that is important in repairing cell damage.
Cells constantly repair damage to their DNA, Cao explained, and they have several ways to get the job done. When one strand in the DNA double helix breaks, cells usually use the unbroken strand as a template to make a perfect copy. PARP-1 is supposed to sense the break and start this repair process. In the study's normal smooth muscle cells, that's what happened.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Studies using brain scans shows that how our brain helps us experience and remember our daily surroundings.
Scientists explore a potential mechanism that a jawless fish called the lampreys employs to swim again after spinal cord injuries.
New study finds that lesbian, gay, and bisexual (LGB) preteens exhibit more social media and mobile phone addiction than straight peers.
The model for memory consolidation claims that the hippocampus forms new memories and, as time goes on, trains the cortex to store enduring memories.
A new study explored the link between T immune cells in ill patients and mortality risk.